Get started
Author

Prema Abraham

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
2008 · Carl D. Regillo, David M. Brown, et al. · American Journal of Ophthalmology · 859
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration
2019 · David S. Liao, Federico V. Grossi, et al. · Ophthalmology · 570
PDF
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
2023 · Jeffrey S Heier, Eleonora M Lad, et al. · The Lancet · 552
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
2010 · Quan Dong Nguyen, Syed Mahmood Shah, et al. · Ophthalmology · 536
Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2
2010 · Prema Abraham, Huibin Yue, et al. · American Journal of Ophthalmology · 442
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
2023 · Arshad M Khanani, Sunil S Patel, et al. · The Lancet · 399
PDF
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
2009 · Quan Dong Nguyen, Syed Mahmood Shah, et al. · Ophthalmology · 340
TENAYA and LUCERNE
2024 · Arshad M. Khanani, Aachal Kotecha, et al. · Ophthalmology · 259
Faricimab Treat-and-Extend for Diabetic Macular Edema
2023 · Tien Y. Wong, Zdenka Haskova, et al. · Ophthalmology · 195
PDF
Retinal Pigment Epithelial Tears After Intravitreal Bevacizumab Injection for Neovascular Age-related Macular Degeneration
2007 · CLEMENT K. CHAN, CARSTEN H. MEYER, et al. · Retina · 166
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2024 · David M Brown, David S Boyer, et al. · The Lancet · 159
PDF
Optical Coherence Tomography–measured Pigment Epithelial Detachment Height as a Predictor for Retinal Pigment Epithelial Tears Associated With Intravitreal Bevacizumab Injections
2010 · CLEMENT K. CHAN, PREMA ABRAHAM, et al. · Retina · 127
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration
2023 · Charles C. Wykoff, David M. Brown, et al. · JAMA Ophthalmology · 125
PDF
Primary Endpoint Results of a Phase II Study of Vascular Endothelial Growth Factor Trap-Eye in Wet Age-related Macular Degeneration
2011 · David M. Brown, Jeffrey S. Heier, et al. · Ophthalmology · 100
Prospective Evaluation of the Incidence and Risk Factors for the Development of Rpe Tears After High- and Low-dose Ranibizumab Therapy
2013 · David Sarraf, Clement Chan, et al. · Retina · 83
Intravitreal Bevacizumab (avastin) in Central Retinal Vein Occlusion
2007 · JASON HSU, RICHARD S. KAISER, et al. · Retina · 63
Ranibizumab for Choroidal Neovascularization Secondary to Causes Other Than Age-Related Macular Degeneration: A Phase I Clinical Trial
2010 · Jeffrey S. Heier, David Brown, et al. · Ophthalmology · 49
Clinical Evaluation of the Safety and Efficacy of Preservative-free Triamcinolone (triesence® [triamcinolone Acetonide Injectable Suspension] 40 Mg/ml) for Visualization During Pars Plana Vitrectomy
2009 · DAVID DYER, DAVID CALLANAN, et al. · Retina · 43
ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation
2024 · Justis P. Ehlers, Allen Hu, et al. · Ophthalmology Science · 40
PDF
Type 1 Versus Type 3 Neovascularization in Pigment Epithelial Detachments Associated With Age-related Macular Degeneration After Anti-vascular Endothelial Growth Factor Therapy
2016 · Xuejing Chen, Mayss Al-Sheikh, et al. · Retina · 40
PDF
Twenty-four–Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes – Protocol 3 with High Dose (READ-3) Study
2016 · Yasir J. Sepah, Mohammad Ali Sadiq, et al. · Ophthalmology · 35
Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy
2021 · Maureen G. Maguire, Danni Liu, et al. · JAMA Ophthalmology · 33
Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration
2014 · C K Chan, P Abraham, et al. · Eye · 29
PDF
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
2023 · Masahiko Shimura, Shigehiko Kitano, et al. · Japanese Journal of Ophthalmology · 23
PDF
Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes
2022 · Clement K. Chan, Maziar Lalezary, et al. · Ophthalmology Retina · 20
Works count: 50
Citation count: 5,403
H-index: 23
I10-index: 31
Year
Topic
Type